Portnoy Law Firm Announces Class Action on Behalf of Perrigo Company plc Investors

LOS ANGELES, Nov. 20, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Perrigo Company plc, (“Perrigo” or the "Company") (NYSE: PRGO) investors off a class action on behalf of investors that bought securities between February 27, 2023 and November 4, 2025, inclusive (the “Class Period”). Perrigo investors have until January 16, 2026 to file a lead plaintiff motion.

Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: lesley@portnoylaw.com, to discuss their legal rights, or join the case via https://portnoylaw.com/perrigo-company-plc. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.

On November 5, 2025, Perrigo issued a press release “announc[ing] that it is initiating a strategic review of its infant formula business” which “will assess a range of alternatives.” Perrigo said that the review “will focus on a combination of accelerating cash flows and reassessing the Company’s previously announced investment in this business of $240 million, while optimizing portfolio impact and focus.” On this news, Perrigo’s stock price fell $5.09 per share, or 25.21%, to close at $15.10 per share on November 5, 2025.

The Portnoy Law Firm represents investors in pursuing claims caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.

Lesley F. Portnoy, Esq.
Admitted CA, NY and TX Bar
lesley@portnoylaw.com
310-692-8883
www.portnoylaw.com

Attorney Advertising

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.